Enterococci, which have been recognized as a cause of many infections, including infectious endocarditis (26) , are the secondto third-most-common pathogens found in hospital-acquired infections. Because of an alarming increase in resistance to different antibiotics, therapy of enterococcal infections has become increasingly difficult. Thus, there is a need for more basic knowledge of these organisms in order to understand how to control or prevent enterococcal infections through developing either therapeutics or vaccines. In a previous report, we described the physical map of the genome of Enterococcus faecalis OG1RF as well as several cosmid clones that complemented Escherichia coli auxotrophs (27) . In this study, the possibility of generating enterococcal pyr and pur auxotrophs by allelic replacement was tested. This methodology is important for developing genetic approaches for studying enterococcal virulence. We also describe the further characterization of a clone containing pyr biosynthesis genes and the determination of the arrangement of the pyr gene cluster by mapping, sequencing, and complementation.
MATERIALS AND METHODS
Bacterial strains, plasmids, and phage. The bacterial strains used in this work are described in Table 1 . The cosmid vector pLAFRx is a derivative of pLAFR which contains oriT of RK2 and a polylinker for cloning (12, 17) . pKV48 and pKV53 are cosmids from the previously constructed enterococcal genomic libraries from E. faecalis OG1RF (Table 1) which complement E. coli pyrC and purL auxotrophs, respectively (27) . The vector used for subcloning was pBluescript II SKϩ phagemid (36) . Transposon mutagenesis was performed by using TnphoA (22) from a TnphoA derivative that also carried the cI857 and P(Am)80 mutations and mini-␥␦-200 (m␥␦) from strain CBK884, obtained from Michael G. Caparon (11) . Lambda cI857 was used for transduction in E. coli.
Media. E. coli transformants and transconjugants were grown on LB agar (25) with appropriate antibiotics. M63 salts (25) supplemented with 0.2% glucose, thiamine (100 g/ml), MgSO 4 (1 mM), and 1.5% agar was used as the minimal medium for growth of E. coli. For testing of possible enterococcal auxotrophs, Davis minimal medium with supplements (DMMS) as described by Murray et al. (27) was used as the defined synthetic enterococcal broth medium. DMMS agar contains 1.5% Bacto Agar (Difco Laboratories, Detroit, Mich.). Uracil or adenosine was added at a concentration of 40 g/ml for the growth of auxotrophs in defined media. The media for electroporation included brain heart infusion (BHI; Difco), BYGT (BHI, yeast extract, glucose, Tris) (8) , and SR (tryptone, yeast extract, sucrose, glucose, gelatin, agar) (7) . Concentrations of antibiotics used for selection were as follows: tetracycline at 12.5 g/ml, chloramphenicol at 20 to 40 g/ml, ampicillin at 150 g/ml, nalidixic acid at 20 g/ml, and kanamycin at 25 g/ml for E. coli and rifampin at 100 g/ml, fusidic acid at 25 g/ml, and kanamycin at 2,000 g/ml for OG1RF.
Routine DNA techniques. Plasmid DNA was isolated by a slightly modified alkaline sodium dodecyl sulfate protocol (4): solution I contained no lysozyme, and solution III was made of 3 M potassium acetate and 5 M glacial acetic acid. Preparation of competent cells and transformation of plasmid DNA were performed as described previously (6) or by electroporation (5) using a Bio-Rad Gene Pulser (Bio-Rad, Hercules, Calif.). Transducing lysate preparation and transduction were performed by using standard procedures (34) . Southern transfer and hybridizations were carried out as described previously (27) . PCR was performed by using a PCR Optimizer Kit (Invitrogen, San Diego, Calif.) and a DNA Thermal Cycler (Perkin-Elmer Cetus, Norwalk, Conn.).
Complementation. The cosmid pKV48 was transferred into E. coli pyrimidine auxotrophic mutants by conjugative mobilization, transformation, or transduction. For conjugative mobilization, E. coli MG1655 containing pKV48, one of the E. coli chloramphenicol-resistant pyrimidine auxotrophs (GE1721 or GE1728; Table 1 ), and the mobilizing strain GE3422, which contains pRK2013 (10), were each grown in LB broth to log phase (about 4 h); 200-l aliquots of the cultures were combined and incubated at 37ЊC for 2 h without shaking. The mating mixture was diluted and spread onto LB-tetracycline-chloramphenicol. For E. coli pyrAa, pyrAb, pyrB, pyrF, and pyrE auxotrophs (Table 1) , pKV48 was introduced by transformation or transduction, selecting for tetracycline resistance. The E. coli pyr auxotrophs containing pKV48 were scored for the ability to grow on the M63 minimal agar. pKV48 derivatives containing transposon insertions were also transduced into the seven E. coli pyr auxotrophs, selecting for both kanamycin and tetracycline resistance. Complementation was tested by comparing colony formation on the following media: M63 agar (30 and 37ЊC), M63-kanamycin and M63-uracil. pKV53 and its derivatives were tested similarly in an E. coli purL mutant (GE1726), with or without adenosine, for complementation.
Transposon mutagenesis. To identify the positions of the pyr genes, pKV48 was mutagenized by using the transposons TnphoA and m␥␦. For mutagenesis with TnphoA, a fresh TnphoA stock was prepared in LE392. E. coli MG1655 containing pKV48 was grown for about 3 h, and TnphoA was added at a multiplicity of infection of approximately 1. Following incubation at 30ЊC for 15 min, the cells were diluted 1:10 into LB broth to allow outgrowth for 4 h at 37ЊC with aeration. Aliquots of 200 l were plated on LB-kanamycin with 40 g of XP (5-bromo-4-chloro-3-indolyl phosphate) per ml and incubated for 2 to 3 days at 37ЊC. Blue colonies were saved separately, and then all colonies were pooled. Cosmids contained in the pool were mobilized to the chloramphenicol-resistant auxotrophic E. coli recipients by triparental mating with W1485 as the helper strain. Strains containing cosmids with a TnphoA insertion(s) were selected on LB-tetracycline-chloramphenicol-kanamycin plates, and then the transposon insertion in the cosmid was confirmed by restriction endonuclease digestion. Thirteen cosmids (named pBEM201 to pBEM213) with TnphoA insertions at different positions in pKV48 were used for subsequent analysis.
To make knockout mutations for construction of subsequent enterococcal mutants with insertions in pyr or pur genes, the transposon m␥␦ was chosen to mutagenize pKV48 and pKV53. The kanamycin resistance determinant in m␥␦ is expressed in both gram-positive and gram-negative hosts and can thus be used as a selective marker for introducing insertions into enterococci. The mutagenesis strain, CBK884(pMGD5, pXRD4043), which contains m␥␦ on a conjugative donor plasmid and a source of ␥␦ transposase, was transformed with pKV48 or pKV53 with selection on LB-tetracycline-kanamycin. A single transformant colony was then grown in 3 ml of LB-chloramphenicol (40 g/ml) with 0.5 mM IPTG (isopropylthiogalactoside) for 3 h to induce transposase production; the recipient strain, LW49, was grown in LB-nalidixic acid. Donor cells (0.5 ml) and 0.2 ml of recipient cells were mixed in an 18-mm-diameter test tube and incubated for 30 min in a 37ЊC water bath without shaking. Then 5 ml of prewarmed LB broth containing IPTG was added, and the mixture was incubated for 3 h without agitation. Exconjugants were selected on LB-tetracycline-kanamycinnalidixic acid. The pools of exconjugants containing pKV48 or pKV53 with m␥␦ insertions were transduced into several E. coli pyr auxotrophs or the pur auxotroph and purified for single colonies. Purified single colonies were then transferred with toothpicks onto both M63 agar and LB-tetracycline-kanamycin. Strains with mutant cosmids that no longer complemented the relevant E. coli auxotroph were saved for subsequent sequencing and allelic replacement studies. Transposon insertions were also mapped according to restriction endonuclease digestion patterns.
Restriction mapping and subcloning. pKV48 and selected derivatives with TnphoA insertions were analyzed by digestion with EcoRI, BamHI, ClaI, and HindIII (Promega, Madison, Wis.), using buffers supplied with the enzymes or KGB reaction buffer (34) . Digested plasmid DNA was electrophoresed in 0.6% ultraPURE electrophoresis-grade agarose (GIBCO BRL, Life Technologies Inc., Gaithersburg, Md.) in 1ϫ TBE (0.09 M Tris base, 0.09 M boric acid, 0.002 M EDTA). The 1-kb DNA ladder and HindIII-digested DNA fragments (GIBCO BRL) were used as molecular weight markers. Determination of fragment sizes by measurements of photographed gels and comparisons of endonuclease restriction patterns were used to generate a restriction map of pKV48.
To generate subclones of pKV48, both pBluescript and pKV48 were double digested with 10 U each of EcoRI and BamHI (Promega) for 2 to 4 h in KGB buffer. Digested DNA was extracted with 1 volume of phenol-chloroformisoamyl alcohol (Amresco, Solon, Ohio), and the supernatant was precipitated with 2 volumes of 95% ethanol. DNA fragments excised from agarose gels were purified by electroelution (38) . Digested pBluescript and pKV48 were then mixed and ligated with 40 U of T4 DNA ligase (New England Biolabs, Beverly, Mass.), using the reaction buffer supplied. All subclones were transformed into E. coli KK2186. Insertions in pBluescript were detected on LB-ampicillin with 2 mg of X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactoside) per plate. White colonies were randomly selected for plasmid extraction and digestions. DNA sequencing and analyses. One-pass DNA sequencing was performed for the pyr and purL genes, with the exception of pyrD, whose DNA sequence was determined until all ambiguities were resolved. The nucleotide sequence of part of the pyr cluster was determined by the dideoxy-chain termination method (35), using automated sequencing (32) . Some of the cluster and most of the pyrD gene were also manually sequenced with 35 S-labeled nucleotides. The Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems Inc.
[ABI], Foster City, Calif.) was used for PCR amplification according to the protocol provided with the kit. Samples were analyzed using an ABI model 373A DNA sequencer. Data were processed with a sequencing analysis program from ABI. The primers used for sequencing included pBluescript T7 and T3 primers (Stratagene, Menasha, Wis.), a primer which is complementary to both inverted repeat sequences of TnphoA (GW26, 5Ј-ACG GGA AAG GAT CCG TCC AGG-3Ј), a primer complementary to one end of m␥␦ (m␥␦-R, 5Ј-GAT TTA GGA TAC ACG GAA TTT CG-3Ј), a primer complementary to the phoA gene in TnphoA (5Ј-CTG AGC AGC CGG GTT TTC CAG AAC AG-3Ј), and primers specific to sequences generated in this study. Both the phoA primer and the m␥␦-R primer, which is complementary to the m␥␦ right-arm sequence, were used for sequencing DNA flanking the transposon. Cosmids pBEM220 (also called pTX5061), pTX5062, pBEM201, pBEM206, pBEM208, pBEM209, pBEM217 to pBEM219, pBEM221, and pBEM222 were used for direct sequencing without subcloning, using the phoA primer or the m␥␦-R primer. The GW26 primer was used when only one of the TnphoA inverted repeats was present such as in pBEM215 and pBEM216. Double-stranded cosmid DNA was prepared for automated sequencing using a Magic Minipreps DNA Purification System Sample Kit (Promega) or by equilibrium centrifugation in CsCl-ethidium bromide gradients (34) .
DNA sequence analysis was performed with the Genetics Computer Group (University of Wisconsin, Madison) sequence analysis package, version 7.2. DNA and protein homology searches were performed with either the BLAST or the FASTA/TFASTA sequence comparison algorithms (30) . Both searches were performed via the GenEMBL and SWISS-PROT databases.
Allelic replacement. Cosmids with m␥␦ insertions that had lost the ability to complement an auxotroph of E. coli (including pBEM220, pTX5062, pBEM217 to pBEM219, and pBEM221) were transformed into OG1RF by using a modification of the electroporation protocol described previously (9) . For preparation of competent cells, OG1RF was grown overnight in BYGT with various glycine concentrations. A concentration of around 6% glycine led to optimal growth inhibition (70 to 90% reduction in optical density at A 660 ). The overnight culture was diluted 10-fold into fresh medium with the same concentration of glycine and incubated for 1 h at 37ЊC. Cells were chilled on ice, harvested by centrifugation at 5,000 ϫ g for 12 min, and washed twice with 1/3 of the original volume of chilled electroporation solution (0.625 M sucrose-1 mM MgCl 2 adjusted to pH 4.0 with 1 N HCl). The washed cells were resuspended in 1/30 of the original volume of electroporation solution and then incubated on ice for 30 to 60 min (or saved at Ϫ70ЊC for later use). Cosmid DNA was prepared by equilibrium centrifugation in CsCl-ethidium bromide gradients. Competent cells (100 to 200 l) were mixed with 2 to 5 g of DNA (in Ͻ20 l of distilled H 2 O or low-salt buffer), added to a chilled 0.2-cm cuvette, and electroporated immediately with a BioRad Gene Pulser apparatus at a capacitance of 25 F, resistance of 200 ⍀, and peak voltage of 2.5 kV (field strength of 8,750 to 10,000 V/cm for E. faecalis). Cells were then incubated in 1 ml of BYGT with 0.25 M sucrose for 90 to 120 min at 37ЊC and plated on SR agar plates containing kanamycin (2,000 g/ml).
After electroporation, colonies growing on the selective plates were further tested by colony hybridization and by Southern hybridization to show the physical structure expected from allelic replacement by homologous recombination. To determine if pLAFRx sequences were present, colony hybridization was carried out as described previously (3), using the whole pLAFRx as a probe. The presence of m␥␦ was verified by using a 2-kb BamHI fragment from m␥␦ as a probe. The probe used for Southern hybridization of TX5066a chromosomal DNA was a 1-kb PCR product containing the pyrD gene generated with primers just upstream and downstream of pyrD. The probe for Southern hybridization of TX5063a chromosomal DNA was a 4-kb EcoRI fragment excised from pKV48.
To simplify the process of screening inactivated pyr genes in E. coli and to identify possible mutations in regions other than structural genes, we tested the possibility of generating enterococcal auxotrophs with allelic replacement by electroporating a pool of different pKV48::m␥␦ insertions. Insertions of m␥␦ into pKV48 were selected as described above, and several hundred of the mutants were pooled. Cosmid DNA was prepared from the pooled cells as described above and used for electroporation of OG1RF. Transformants were selected on BHI-kanamycin (2,000 g/ml) and saved for further analysis, including growth in DMMS broth and agar. Southern blotting was performed to map the insertions in OG1RF, with pKV48 as the probe.
Growth curves. The phenotype of the OG1RF::m␥␦ derivatives created by allelic replacement was first screened on DMMS agar as described above and then tested in DMMS broth. For growth in broth, OG1RF strains were grown overnight in BHI broth, harvested, washed twice with 0.9% NaCl, and then added to the DMMS broth at a final inoculum of 10 7 CFU/ml. The cell densities of OG1RF and the OG1RF transposon insertion mutants were determined by measuring the optical density at A 660 and Klett units. Growth of cultures with and without adenosine or uracil was assessed by Klett units and colony counts at various times over 18 h of incubation (shaken at 300 rpm) at 37ЊC.
Nucleotide sequence accession numbers. The sequences reported have been submitted to GenBank and assigned accession numbers as follows: pyrR, U25091; pyrP, U25095; pyrB, U25092; pyrC, U25093; pyrAb, U25090; pyrD, U24692; pyrF, U25094; pyrE, U24682; and pyrAa, U36195.
RESULTS

Complementation and transposon mutagenesis.
Previous studies have shown that a pyrC mutant of E. coli was complemented by the cosmid clone pKV48 (27) . The possibility that pKV48 could complement other mutations in the pyrimidine biosynthesis pathway was tested by introducing this cosmid into various E. coli pyr mutants and scoring for their abilities to grow on minimal media (Table 2 ). Prototrophy was restored for E. coli pyrAa, pyrAb, pyrB, pyrC, pyrD, pyrF, and pyrE auxotrophs, indicating that genes encoding analogous products were contained in the cosmid. The E. coli pyrAa and pyrAb (also referred to as carA and carB) mutants require both arginine and uracil. These auxotrophs were complemented by pKV48 on minimal media in the presence of arginine but not in its absence or when only uracil was present. Although the pyrimidine biosynthesis functions are spread throughout the E. coli chromosome, they are clearly clustered in E. faecalis. This result is similar to that found for Bacillus species (14, 33) .
Mapping pyr genes by transposon mutagenesis. Thirteen TnphoA insertions and six m␥␦ insertions were isolated and mapped in pKV48 ( Fig. 1 and Table 1 ). Cosmids with representative insertions were tested for complementation in seven E. coli pyr gene mutants (Table 2) . Among the TnphoA insertion derivatives of pKV48, pBEM207, pBEM208, and pBEM 209 (with insertions at positions 207, 208, and 209, respectively) had lost the ability to complement the pyrC, pyrAa, and pyrAb mutations. pBEM205 and pBEM206 had lost the ability to complement the E. coli pyrAa and pyrAb auxotrophs. pBEM 202 and pBEM203 had lost the ability to complement the pyrD mutation, while pBEM204 complemented pyrD and therefore may lie outside this gene. pBEM201 failed to complement the pyrF mutant. pBEM210 complemented pyrC, suggesting that the insertion at position 210 and the upstream insertions at positions 211, 212, and 213 lie outside the pyrimidine gene cluster. This was verified by subsequent sequencing from the insertion at position 209 (see below). Colonies of E. coli carrying pBEM207 and pBEM208, with TnphoA insertions in pyrP (see below), were blue on LB agar containing XP, suggesting that the transposon insertions at positions 207 and 208 were in a gene encoding a protein exported in E. coli.
Among the m␥␦ insertion derivatives, pBEM218 and pBEM 219 did not complement pyrC, pyrAa, or pyrAb, while pBEM 220 and pBEM221 did not complement pyrD. pBEM217 did not complement the pyrE mutant, and pBEM222 did not complement the pyrAa mutant, the only strain with which it was tested.
Since all insertion mutants complemented the E. coli pyrB mutant, there was a possibility that pKV48 contained a pyrB function outside the pyrimidine gene cluster. To test this, plasmid pBEM215 was used. This plasmid contains the left side of the insert in pKV48 and lacks most of the pyrimidine gene cluster, including the region found to encode pyrB (see below). Plasmid pBEM215 did not complement the E. coli pyrB mutant (data not shown), making it unlikely that a pyrB gene is encoded outside of the pyrimidine gene cluster on pKV48.
Restriction mapping and sequencing of pKV48. The restriction map of pKV48 was generated by using EcoRI, BamHI, ClaI, or HindIII digestion of pKV48 and the 13 TnphoA insertion derivatives (Fig. 1) . In most cases, both single and double digestions, and occasionally triple digestions, were performed. To facilitate sequencing and ordering of the genes contained in pKV48, three subclones, pBEM214, pBEM215, and pBEM 216, were constructed (Fig. 1) . Subclone pBEM214 contains a 3-kb EcoRI-BamHI fragment of pKV48 spanning the TnphoA insertions at positions 202 and 203 which had resulted in loss of pyrD complementation. Subclone pBEM215 was generated by deleting two adjacent BamHI fragments (11 and 4.7 kb) from pBEM207, which is pKV48 with a TnphoA insertion at position 207. The 11-kb deleted BamHI fragment includes one arm of the inserted TnphoA. The remaining large fragment (about 37 kb) containing the other arm of TnphoA, including its kanamycin resistance gene, was self-ligated. An additional clone was constructed by excising and purifying the 11-kb BamHI fragment from pBEM207 and further digesting it with NotI and HindIII. A 2.5-kb NotI-HindIII fragment was ligated into appropriately digested pBluescript to produce pBEM216. Both pBEM215 and pBEM216 contain one of the TnphoA207 inverted repeats and thus contain sequences complementary to the GW26 primer, which was used to prime DNA sequencing reactions. Enterococcal sequences contained in pBEM216 and pBEM215 are contiguous to each other at position 207.
The subclone pBEM214 was first sequenced from one end, by using the pBluescript T3 primer. The first 225 nucleotides demonstrated homology with the orf2 (open reading frame 2) sequence from Bacillus subtilis and B. caldolyticus, whose pyr genes are organized in similar clusters (14, 33) . New primers were designed on the basis of the DNA sequence obtained and were used to extend the sequencing. In this way, both strands of the entire pyrD gene as well as part of the pyrF gene were sequenced. Most of the pyrD sequence was also obtained by manual sequencing of both strands. The pyrD gene is 936 nucleotides long in B. subtilis, while the enterococcal pyrD sequence is either 939 or 936 nucleotides long, depending on which of two adjacent ATG codons is used for initiation of translation. The predicted E. faecalis PyrD amino acid sequence showed 79 to 81% similarity to PyrD from B. subtilis and B. caldolyticus and 53% similarity to PyrD from E. coli, reflecting the closer phylogenetic relationship among grampositive organisms. Recently, another gram-positive organism, Lactococcus lactis, was shown to contain two pyrD genes (1). The E. faecalis PyrD protein shows 88% similarity (73% identity) to PyrDb of L. lactis.
The initial 270-nucleotide sequence from the subclone pBEM216, obtained by using the GW26 primer, revealed homology with pyrP of B. subtilis and B. caldolyticus (13, 37) . Using a primer based on the pyrP sequence, we found that the next 300-nucleotide sequence had homology with the pyrB gene of these organisms. Sequencing from the other end of the 2.5-kb insert in pBEM216 by using the pBluescript T7 primer revealed a region of sequence similarity to pyrC, located about 5.5 kb upstream from pyrD in pKV48. Sequencing of about 200 nucleotides from pBEM215 by using the GW26 primer verified the expected pyrP sequence, which was continuous with the downstream pyrP sequence in pBEM216. The pyrP sequence was also obtained from direct sequencing of pBEM208 as described above. Using the phoA primer to sequence the region flanking TnphoA in cosmid pBEM206, which had lost the ability to complement pyrAb, we obtained 254 nucleotides of sequence similar to pyrAb of B. subtilis and B. caldolyticus. Similarly, sequence from the m␥␦ insertion in cosmid pBEM222, which had lost the ability to complement pyrAa, provided a 310-nucleotide sequence that was similar to pyrAa of B. subtilis and B. caldolyticus. The pyrR homolog was sequenced from the insertion at position 209 by using the phoA primer and from the downstream insertion at position 218 by using the m␥␦-R primer. Computer analysis showed that the insertion at position 209 is about 40 nucleotides upstream of the predicted pyrR gene. Sequences flanking m␥␦ insertions at positions 217 and 219 revealed similarity to pyrE and pyrC, respectively, of Bacillus spp. (Fig. 1) . Insertions at positions 220 and 221 were about 120 nucleotides apart. In all, the lengths of the 10 sequenced regions (pyrR, pyrP, pyrB, pyrC, pyrAa, pyrAb, orf2, pyrD, pyrF, and pyrE) varied from 180 (pyrF) to 939 (pyrD) nucleotides, and their DNA sequence similarity to the corresponding genes of B. subtilis and B. caldolyticus varied from 50 to 69%. The partial pyrP nucleotide and predicted peptide sequences were compared with the E. coli uracil permease sequence; the 296-nucleotide sequences showed 53% identity, and the predicted peptide sequences showed 78.3% similarity (data not shown). According to the map and sequence information, the distance from pyrB to pyrD in pKV48 is approximately 7.5 kb, while that between pyrB and pyrD in B. subtilis and B. caldolyticus is 7.2 kb. The distance between pyrC and pyrD and the distance between pyrAb and pyrD in E. faecalis were also very close to those in B. subtilis and B. caldolyticus. The alignment of the pyr gene cluster of these three organisms demonstrated that the organization in E. faecalis is very similar to that in B. subtilis and B. caldolyticus. Using the complete sequences from Bacillus spp., we determined the possible positions of the insertions in the pyr genes (Table 3) .
Isolation and characterization of insertions in the purL gene. The cosmid pKV53 was previously shown to complement an E. coli purL auxotroph (27) . Using m␥␦, we performed mutagenesis with this cosmid. When the pool of pKV53 with m␥␦ insertions was transduced into an E. coli purL auxotroph and selected as before, a colony with a mutant cosmid, designated pTX5062, that no longer complemented the E. coli auxotroph was isolated. Insertion of the transposon into purL of pTX5062 was confirmed by sequence analysis using the m␥␦-R primer to prime the sequencing reaction. The purL gene of B. subtilis encodes a 228-amino-acid-long polypeptide. The transposon insertion in the E. faecalis purL gene was at a position corresponding to codon 21 (Table 3) .
Allelic replacement. We next tested the possibility of gener- ating pyr or pur auxotrophs of enterococci by using the insertion mutants described above. Cosmids containing m␥␦ insertions in the pyrR, pyrC, pyrD (two different insertions), pyrE, and purL genes ( Table 2) were electroporated into OG1RF competent cells. Transformants that survived on kanamycin (2,000 g/ml) were expected to result from recombination between the cosmid and the host chromosome because pLAFRx cannot replicate in enterococci. Southern blot analysis confirmed the locations of the transposon insertions in the chromosome of E. faecalis and showed that only a single insertion was present.
Transformants were tested for auxotrophy by measuring growth on DMMS with or without uracil or adenosine supplements (Table 3 ). The transposon insertion mutants from pyrC, pyrE, and purL mutants grew poorly on DMMS agar, forming microcolonies, as well as in DMMS broth unless uracil or adenosine was added. The pyrR mutant showed intermediate growth under these conditions, possibly because of an incomplete polar effect on downstream genes. In contrast, both pyrD mutants showed growth that was comparable to that of the wild-type parent on DMMS agar or in broth.
The insertion mutations in E. faecalis were stable, as no revertants were observed for pyrE or purL (frequency of Ͻ10
Ϫ8
) when these mutants were plated on DMMS agar. A single revertant of the pyrC insertion (TX5078), which grew well on DMMS agar, was detected at a frequency of less than 10
. The revertant was still resistant to 2,000 g of kanamycin per ml, suggesting that the m␥␦ transposon was still present. Presumably a rare second-site mutation was responsible for the phenotype.
Because the pyrD insertions did not produce auxotrophy in enterococci, the m␥␦220 insertion mutant was analyzed in more detail. Thirteen putative OG1RFpyrD::m␥␦220 isolates hybridized with a probe from m␥␦ but not with pLAFRx, indicating that kanamycin-resistant cells arose from a double crossover between the cosmid and the host chromosome (data not shown). Southern blots of DNA from two pyrD::m␥␦220 mutants (strains TX5066a and TX5066b) digested with BamHI plus EcoRI were hybridized with the 1-kb pyrD probe, and the results confirmed the correct allele replacement ( Fig. 1 and 2) . Finally, PCR of TX5066a was performed with a primer derived from the end of pyrD and a primer from within m␥␦. The amplified fragment was subjected to DNA sequence analysis, which verified that the m␥␦ insertion was located in the pyrD gene. These results allowed us to conclude that insertion of m␥␦ in the pyrD gene does not create an auxotrophic phenotype in E. faecalis.
Chromosome replacement en masse. We wished to determine if a more efficient method for identification of biosynthetic genes (or any phenotypic class) could be performed in enterococci. To this end, we pooled several hundred m␥␦ insertions in pKV48, isolated DNA, and electroporated the DNA into E. faecalis OG1RF. Twenty-three kanamycin-resistant colonies were analyzed, and one was found to have a pyrimidine requirement (Table 3) . Southern blot analysis of this mutant (TX5081) showed it to have an insertion in the pyr gene cluster (data not shown), although the specific gene location was not determined. Thus, one can identify specific E. faecalis functions (e.g., metabolic genes) by this procedure without relying on heterologous complementation or other laborious procedures.
DISCUSSION
We show in this report that following transposon mutagenesis in E. coli, it is possible to construct auxotrophic knockout mutants of E. faecalis. Both pyrimidine-and purine-requiring auxotrophs, the first auxotrophic mutants of an enterococcal strain, were generated by this procedure. Clearly, mutations in any gene giving a phenotype that is detectable in E. coli could be isolated by this procedure. This should have particular applicability to genes involved in infection or other host interactions. Such genes could be detected in E. coli by using antisera from patients or other procedures.
The genes coding for de novo pyrimidine biosynthesis have been extensively studied in E. coli and B. subtilis. In E. coli, the pyr genes are scattered around the chromosome and are not coordinately regulated (28) . Pyrimidine-mediated regulation of expression of pyrBI and pyrE in E. coli has been shown to occur primarily by transcriptional attenuation (20) . In B. subtilis, the genes encoding enzymes in the pyrimidine biosynthesis pathway are clustered on the chromosome and appear to be coordinately regulated (29, 31, 37) . Expression is believed to occur from a promoter upstream from pyrR, producing a single transcript, that is negatively regulated by pyrR (37) . At least one of these genes, pyrB, which encodes aspartate transcarbamylase, is regulated developmentally (23) .
Little was previously known about the organization of pyr genes or their regulation in enterococci. In this study, we used a defined medium, developed previously in this laboratory (27) , to identify auxotrophs. It is clear that E. faecalis resembles Bacillus spp. with respect to organization of the pyr gene cluster. This resemblance is supported by the functional analysis of several genes and by complementation of E. coli mutants. It should also be noted that two TnphoA insertions into the pyrP gene, thought to encode a permease, gave blue colonies on XP medium, indicating export of the enterococcal pyrP gene product in E. coli. Thus, it is likely that this function is also conserved.
The regulation of expression of the pyr gene cluster in E. faecalis also appears to share features with the same regulation in Bacillus spp. Thus, an insertion in pyrR (m␥␦218) showed reduced growth in DMMS, consistent with a polar effect of this insertion on downstream pyr genes. If pyrR is a negative regulator as in Bacillus spp., we would expect overexpression in addition to polar effects on downstream genes. Perhaps this explains the partial auxotrophic phenotype.
Results of complementation in E. coli are more difficult to interpret, presumably because of the heterologous nature of the system. Insertions in pyrR, pyrP, or pyrC are deficient in complementation for downstream functions (except for pyrB) down to the pyrAa and pyrAb genes ( Table 2 ). This finding is consistent with expression in E. coli of these enterococcal genes from a single promoter, upstream from pyrR. Note that complementation by these genes is also defective in the mutant with TnphoA209, which is inserted upstream from pyrR, con- The pyrB gene in pKV48 derivatives containing upstream transposon insertions, however, complements an E. coli mutant despite the fact that its expression should be reduced in some of these mutants. The reason for this anomaly is not known. Another unusual result is the loss of complementation for pyrAa in an insertion mutant in the pyrAb gene (TnphoA206; Table 2 ). Effects of pyrAb knockout mutations on pyrAa have been reported previously (15) and may reflect the subunit nature of this enzyme. Another anomaly in the heterologous system is the complementation of the E. coli pyrD, pyrF, and pyrE mutants by these mutant cosmids (Table 2) . Similarly, E. coli pyrF and pyrE mutants are complemented by cosmids with insertions in the pyrD gene ( Table 2 ). Assuming that m␥␦ and TnphoA insertions show polarity, these results are not consistent with a single transcript being produced in E. coli. Perhaps there are internal promoters in the pyr gene cluster that function in E. coli. Whether such promoters are physiologically significant in E. faecalis is not known. It is also possible that the anomalous complementation of pyrB, pyrD, pyrF, and pyrE reflects a requirement for smaller amounts of these gene products than for the other pyr functions.
The observation that two independent pyrD knockout mutants, located centrally in the coding sequence, were not auxotrophs suggests that the PyrD function in E. faecalis may be duplicated, as in L. lactis. The two proteins in L. lactis show only 24% sequence identity, with PyrDa being related to the enzyme from Saccharomyces cerevisiae (70% identity) and PyrDb being related to the enzyme from B. subtilis (64% identity) (1) . If this situation held for E. faecalis, it would explain why we did not detect the second gene by either Southern blot or PCR analysis, since the sequences of the E. faecalis pyrD and the L. lactis pyrDa genes are significantly different. Inspection of the pathway for de novo UMP synthesis (Fig. 3) shows that auxotrophs were isolated for steps before and after the reaction performed by the pyrD-encoded enzyme. The observation that auxotrophs were obtained for steps preceding the pyrDdependent reaction suggests that there is no alternative pathway for synthesizing orotic acid.
Auxotrophs of E. faecalis may also be useful in studies of virulence. For example, in other systems, auxotrophs have been used to develop attenuated live vaccine strains (19) . In addition, auxotrophic mutants were used to identify Salmonella genes that were expressed during infection (21) . Such an in vivo expression procedure could be used for selection of enterococcal virulence genes that are specifically induced in host tissues.
